James Johnson
Directeur/Bestuurslid bij ATHIRA PHARMA, INC.
Vermogen: 9 600 $ op 30-04-2024
Actieve functies van James Johnson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ATHIRA PHARMA, INC. | Directeur/Bestuurslid | 01-08-2020 | - |
Independent Dir/Board Member | 01-08-2020 | - |
Loopbaan van James Johnson
Eerdere bekende functies van James Johnson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Financieel Directeur/CFO | 01-01-2018 | 01-08-2019 |
NANOSTRING TECHNOLOGIES, INC. | Comptroller/Controller/Auditor | 03-10-2012 | 31-12-2017 |
Financieel Directeur/CFO | 03-10-2012 | 31-12-2017 | |
RELYPSA INC | Financieel Directeur/CFO | 01-05-2011 | 01-09-2012 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Financieel Directeur/CFO | 01-02-2001 | 01-10-2010 |
Bedrijfssecretaris | 28-05-2010 | 01-10-2010 | |
Treasurer | 01-02-2001 | 01-10-2010 | |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Hoofd Administratief Officier | 01-01-1999 | 01-02-2001 |
Financieel Directeur/CFO | 01-01-1994 | 01-02-2001 | |
Bedrijfssecretaris | 01-01-1994 | 01-02-2001 | |
Treasurer | 01-01-1994 | 01-02-2001 | |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Financieel Directeur/CFO | 01-01-1988 | 01-01-1994 |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Financieel Directeur/CFO | - | - |
Opleiding van James Johnson
University of Washington | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 10 |
Operationeel
Director of Finance/CFO | 7 |
Corporate Secretary | 2 |
Treasurer | 2 |
Sectoraal
Health Technology | 9 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
NANOSTRING TECHNOLOGIES, INC. | Health Technology |
ATHIRA PHARMA, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Health Technology |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Health Technology |
- Beurs
- Insiders
- James Johnson
- Ervaring